A detailed history of Israel Englander (Millennium Management LLC) transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Millennium Management LLC holds 816,456 shares of ADCT stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
816,456
Previous 1,010,437 19.2%
Holding current value
$2.61 Million
Previous $4.54 Million 43.12%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.55 - $5.09 $494,651 - $987,363
-193,981 Reduced 19.2%
816,456 $2.58 Million
Q1 2024

May 15, 2024

SELL
$1.66 - $5.29 $2.76 Million - $8.79 Million
-1,662,373 Reduced 62.2%
1,010,437 $4.54 Million
Q4 2023

Feb 14, 2024

BUY
$0.47 - $1.79 $586,870 - $2.24 Million
1,248,661 Added 87.68%
2,672,810 $4.44 Million
Q2 2023

Aug 14, 2023

SELL
$1.9 - $2.66 $701,181 - $981,654
-369,043 Reduced 20.58%
1,424,149 $3.06 Million
Q1 2023

May 15, 2023

SELL
$1.92 - $5.45 $3.09 Million - $8.76 Million
-1,607,928 Reduced 47.28%
1,793,192 $3.5 Million
Q4 2022

Feb 14, 2023

BUY
$2.87 - $5.24 $8.56 Million - $15.6 Million
2,980,867 Added 709.3%
3,401,120 $13.1 Million
Q3 2022

Nov 14, 2022

BUY
$4.66 - $10.31 $1.69 Million - $3.74 Million
362,288 Added 625.01%
420,253 $2.03 Million
Q2 2022

Aug 15, 2022

BUY
$5.96 - $14.99 $345,471 - $868,895
57,965 New
57,965 $461,000
Q1 2022

May 16, 2022

SELL
$13.28 - $20.03 $536,073 - $808,551
-40,367 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$19.29 - $31.51 $778,679 - $1.27 Million
40,367 New
40,367 $815,000
Q1 2021

May 17, 2021

SELL
$22.75 - $34.05 $675,197 - $1.01 Million
-29,679 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$25.26 - $38.02 $52,237 - $78,625
-2,068 Reduced 6.51%
29,679 $950,000
Q3 2020

Nov 16, 2020

BUY
$32.87 - $51.05 $554,188 - $860,703
16,860 Added 113.25%
31,747 $1.05 Million
Q2 2020

Aug 14, 2020

BUY
$29.65 - $46.81 $441,399 - $696,860
14,887 New
14,887 $697,000

Others Institutions Holding ADCT

About ADC Therapeutics SA


  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $248M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.